BNR
Price
$11.32
Change
-$0.89 (-7.29%)
Updated
Nov 13 closing price
Capitalization
121.88M
Intraday BUY SELL Signals
TGLVY
Price
$0.57
Change
+$0.06 (+11.76%)
Updated
Nov 13 closing price
Capitalization
1.21B
Intraday BUY SELL Signals
Interact to see
Advertisement

BNR vs TGLVY

Header iconBNR vs TGLVY Comparison
Open Charts BNR vs TGLVYBanner chart's image
Burning Rock Biotech
Price$11.32
Change-$0.89 (-7.29%)
Volume$17.27K
Capitalization121.88M
Top Glove
Price$0.57
Change+$0.06 (+11.76%)
Volume$648
Capitalization1.21B
BNR vs TGLVY Comparison Chart in %
BNR
Daily Signal:
Gain/Loss:
TGLVY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BNR vs. TGLVY commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNR is a Hold and TGLVY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BNR: $11.32 vs. TGLVY: $0.57)
Brand notoriety: BNR and TGLVY are both not notable
BNR represents the Medical Specialties, while TGLVY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BNR: 65% vs. TGLVY: 28%
Market capitalization -- BNR: $121.88M vs. TGLVY: $1.21B
BNR [@Medical Specialties] is valued at $121.88M. TGLVY’s [@Pharmaceuticals: Other] market capitalization is $1.21B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $200.47B to $0. The average market capitalization across the [@Medical Specialties] industry is $12.08B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNR’s FA Score shows that 1 FA rating(s) are green whileTGLVY’s FA Score has 1 green FA rating(s).

  • BNR’s FA Score: 1 green, 4 red.
  • TGLVY’s FA Score: 1 green, 4 red.
According to our system of comparison, BNR is a better buy in the long-term than TGLVY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNR’s TA Score shows that 4 TA indicator(s) are bullish while TGLVY’s TA Score has 4 bullish TA indicator(s).

  • BNR’s TA Score: 4 bullish, 5 bearish.
  • TGLVY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BNR is a better buy in the short-term than TGLVY.

Price Growth

BNR (@Medical Specialties) experienced а -7.59% price change this week, while TGLVY (@Pharmaceuticals: Other) price change was +10.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.21%. For the same industry, the average monthly price growth was +1.82%, and the average quarterly price growth was +31.26%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.10%. For the same industry, the average monthly price growth was +0.50%, and the average quarterly price growth was +6.41%.

Industries' Descriptions

@Medical Specialties (+1.21% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+2.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGLVY($1.21B) has a higher market cap than BNR($122M). BNR YTD gains are higher at: 67.704 vs. TGLVY (-55.096). TGLVY has higher annual earnings (EBITDA): 482M vs. BNR (-211.78M). TGLVY has more cash in the bank: 561M vs. BNR (495M). BNR has less debt than TGLVY: BNR (42.3M) vs TGLVY (850M). TGLVY has higher revenues than BNR: TGLVY (3.49B) vs BNR (523M).
BNRTGLVYBNR / TGLVY
Capitalization122M1.21B10%
EBITDA-211.78M482M-44%
Gain YTD67.704-55.096-123%
P/E RatioN/A43.25-
Revenue523M3.49B15%
Total Cash495M561M88%
Total Debt42.3M850M5%
FUNDAMENTALS RATINGS
TGLVY: Fundamental Ratings
TGLVY
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNRTGLVY
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 8 days ago
70%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 19 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BNR
Daily Signal:
Gain/Loss:
TGLVY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMTDF26.20N/A
N/A
Sumitomo Mitsui Trust Group, Inc.
THVB88.00N/A
N/A
Thomasville Bancshares, Inc.
FRTAY16.68N/A
N/A
Freenet AG
MANOF1.13N/A
N/A
Manolete Partners Plc
FTIDF0.18N/A
N/A
FTI Foodtech International, Inc.

BNR and

Correlation & Price change

A.I.dvisor tells us that BNR and ZOMDF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNR and ZOMDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNR
1D Price
Change %
BNR100%
-7.29%
ZOMDF - BNR
28%
Poorly correlated
-2.25%
RVTY - BNR
25%
Poorly correlated
-0.78%
ACRS - BNR
24%
Poorly correlated
-3.73%
STXS - BNR
24%
Poorly correlated
-7.82%
ANGO - BNR
23%
Poorly correlated
-2.84%
More

TGLVY and

Correlation & Price change

A.I.dvisor tells us that TGLVY and BNR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TGLVY and BNR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGLVY
1D Price
Change %
TGLVY100%
+0.65%
BNR - TGLVY
20%
Poorly correlated
+2.26%
SSMXY - TGLVY
12%
Poorly correlated
-0.95%
VPTDF - TGLVY
8%
Poorly correlated
+0.84%
TRUMY - TGLVY
3%
Poorly correlated
-6.35%
SUVPF - TGLVY
2%
Poorly correlated
N/A
More